{"nctId":"NCT01007994","briefTitle":"Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients","startDateStruct":{"date":"2009-11","type":"ACTUAL"},"conditions":["Hypertension Secondary to Kidney Transplant"],"count":33,"armGroups":[{"label":"New Medication","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: New Medication: Enalapril, Isradipine, Propranolol"]},{"label":"Control","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"New Medication: Enalapril, Isradipine, Propranolol","otherNames":["Vasotec, DynaCirc, Inderal"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects age 5-21 years\n* Stable kidney transplant recipients (\\<30% change in eGFR in past 3 months)\n* eGFR \\> 30 ml/min/1.73 m2\n* \\>6 months since kidney transplant\n* ABPM: Non-dipper status defined as \\<10% decline in systolic or diastolic blood pressure from daytime to night-time\n\nExclusion Criteria:\n\n* ABPM: Subjects with daytime mean blood pressure \\> 95% for height and sex\n* Subjects on diuretic monotherapy will not be eligible for the time change group (to avoid discomfort of nocturnal enuresis)\n* Subjects with nephrotic range proteinuria\n* Subjects with major co-morbid conditions such as cardiac disease, pulmonary disease and diabetes mellitus\n* Subjects/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures\n* Subjects who are pregnant will not be eligible for the new medication group","healthyVolunteers":false,"sex":"ALL","minimumAge":"5 Years","maximumAge":"21 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Who Are Non Dippers","description":"Percentage of subjects in each of the treatment arms who are nondippers, defined as systolic or diastolic nocturnal dip \\<10%","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":17},"commonTop":["Hyperkalemia"]}}}